Thomas Stephen Basil (CIK 2027962) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-17). Recent activity: Sell CLYM (100,000 shares), Sell CLYM (33,687 shares), Sell CLYM (16,313 shares), Sell CLYM (90,000 shares), Sell CLYM (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | Climb Bio, Inc. (CLYM) | Director | Sell | 100,000 | $1.4M |
| 2026-02-27 | Climb Bio, Inc. (CLYM) | Director | Sell | 33,687 | $235,809 |
| 2026-02-27 | Climb Bio, Inc. (CLYM) | Director | Sell | 16,313 | $114,354 |
| 2026-02-17 | Climb Bio, Inc. (CLYM) | Director | Sell | 90,000 | $470,700 |
| 2026-02-17 | Climb Bio, Inc. (CLYM) | Director | Sell | 10,000 | $58,100 |
| 2025-08-11 | Climb Bio, Inc. (CLYM) | Director | Buy | 100,375 | $0 |
| 2025-07-01 | Climb Bio, Inc. (CLYM) | Director | Buy | 25,094 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-17